Australia to fund accelerated trial of 'next generation' vaccines and transmission-reducing measures for COVID-19

Australian Health Minister Greg Hunt announced funding for trials of two 'next generation' vaccines which could be rapidly changed to account for mutations of the COVID-19 virus.

The University of Melbourne will trial these "recombinant protein and mRNA vaccines", which will potentially have numerous advantages over 'first generation' vaccines such as not requiring extremely low-temperature storage.

The funding was allocated as part of a broader A$10 million (US$7 million) package of research on managing COVID-19 transmission.

Press release - Department of Health